PEVIANI, MARCO
 Distribuzione geografica
Continente #
NA - Nord America 1.548
AS - Asia 1.060
EU - Europa 863
SA - Sud America 123
AF - Africa 39
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.634
Nazione #
US - Stati Uniti d'America 1.510
CN - Cina 474
SG - Singapore 259
IE - Irlanda 189
IT - Italia 148
HK - Hong Kong 133
RU - Federazione Russa 117
BR - Brasile 90
VN - Vietnam 85
DE - Germania 84
FI - Finlandia 76
UA - Ucraina 63
FR - Francia 49
GB - Regno Unito 37
IN - India 32
SE - Svezia 30
CA - Canada 22
ZA - Sudafrica 20
BE - Belgio 18
MX - Messico 13
AR - Argentina 12
PL - Polonia 12
ES - Italia 11
ID - Indonesia 9
JP - Giappone 9
BD - Bangladesh 8
IQ - Iraq 8
NL - Olanda 8
TR - Turchia 6
VE - Venezuela 6
CO - Colombia 5
LT - Lituania 5
PH - Filippine 5
AT - Austria 4
KE - Kenya 4
PK - Pakistan 4
UZ - Uzbekistan 4
DK - Danimarca 3
EG - Egitto 3
KR - Corea 3
KZ - Kazakistan 3
MA - Marocco 3
PE - Perù 3
SA - Arabia Saudita 3
BO - Bolivia 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
EC - Ecuador 2
IR - Iran 2
KH - Cambogia 2
MY - Malesia 2
PT - Portogallo 2
TN - Tunisia 2
AL - Albania 1
AZ - Azerbaigian 1
CH - Svizzera 1
CL - Cile 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
GA - Gabon 1
GR - Grecia 1
HU - Ungheria 1
JM - Giamaica 1
JO - Giordania 1
KG - Kirghizistan 1
KW - Kuwait 1
LY - Libia 1
ML - Mali 1
MN - Mongolia 1
NG - Nigeria 1
NP - Nepal 1
OM - Oman 1
PS - Palestinian Territory 1
PY - Paraguay 1
RO - Romania 1
SN - Senegal 1
TH - Thailandia 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 3.634
Città #
Dallas 215
Dublin 189
Chandler 175
Singapore 142
San Jose 135
Hong Kong 132
Ashburn 124
Beijing 107
Nanjing 100
Jacksonville 80
Ann Arbor 54
Pavia 54
Boardman 51
Lauterbourg 37
Los Angeles 36
Princeton 35
Lawrence 34
Helsinki 31
Wilmington 31
Nanchang 29
New York 28
Munich 27
Ho Chi Minh City 23
Medford 23
Moscow 23
Milan 21
Redondo Beach 21
Hanoi 20
Piscataway 19
Shanghai 19
Buffalo 18
Hebei 18
Johannesburg 16
São Paulo 16
Changsha 15
Jiaxing 15
Brussels 14
Orem 13
Shenyang 13
Tianjin 13
The Dalles 12
Warsaw 12
Chicago 11
Chennai 9
Mexico City 9
Seattle 9
Toronto 9
Woodbridge 9
Council Bluffs 8
Denver 8
Tokyo 8
Turku 8
New Delhi 7
Rome 7
Stockholm 7
Chongqing 6
Da Nang 6
Falls Church 6
Frankfurt am Main 6
Hangzhou 6
Manchester 6
Montreal 6
Santa Clara 6
Washington 6
Atlanta 5
Columbus 5
Mumbai 5
Nuremberg 5
Des Moines 4
Haiphong 4
Houston 4
Jinan 4
Phoenix 4
Piemonte 4
Pune 4
Tappahannock 4
Tashkent 4
Thái Nguyên 4
Amsterdam 3
Ankara 3
Boston 3
Caracas 3
Curitiba 3
Dhaka 3
Erbil 3
Fairfield 3
Guangzhou 3
Lima 3
London 3
Nairobi 3
Naples 3
Newark 3
Paris 3
Poplar 3
Qingdao 3
Rio de Janeiro 3
Secaucus 3
Apucarana 2
Auburn Hills 2
Baghdad 2
Totale 2.476
Nome #
(R)-RC-33 as Promising Neuroprotective Agent Acting as Sigma1 Receptor Agonist 157
Studies on the Enantiomers of RC-33 as Neuroprotective Agents: Isolation, Configurational Assignment, and Preliminary Biological Profile 145
A step forward in the sigma enigma: a role for chirality in the sigma1 receptor- ligand interaction? 143
Chemical, pharmacological, and in vitro metabolic stability studies on enantiomerically pure RC-33 compounds, promising neuroprotective agents acting as sigma1 receptor agonists. 142
Essential Amino Acid Supplementation May Attenuate Systemic Inflammation and Improve Hypoalbuminemia in Subacute Hemiplegic Stroke Patients 141
Identification of RC-33 as a potent and selective sigma1 receptor agonist potentiating NGF-induced neurite outgrowth in PC12 cells. Part 2: g-scale synthesis, physicochemical characterization and in vitro metabolic stability. 137
Identification of a potent and selective sigma1 receptor agonist potentiating NGF-induced neurite outgrowth in PC12 cells. 124
Development of easy-to-use reverse-phase liquid chromatographic methods for determining PRE-084, RC-33 and RC-34 in biological matrices. The first step for in vivo analysis of sigma1 receptor agonists. 116
Accumulation of human SOD1 and ubiquitinated deposits in the spinal cord of SOD1G93A mice during motor neuron disease progression correlates with a decrease of proteasome. 115
COMPOSITIONS AND METHODS FOR TARGETING CELLS 110
In Situ Agar – Carbomer Hydrogel Polycondensation:a Chemical Approach to Regenerative Medicine 108
COMPOSITIONS AND METHODS FOR TREATING DISEASES AND DISORDERS OF THE CENTRAL NERVOUS SYSTEM 105
Differences in protein quality control correlate with phenotype variability in 2 mouse models of familial amyotrophic lateral sclerosis 102
Bitopic Sigma 1 Receptor Modulators to Shed Light on Molecular Mechanisms Underpinning Ligand Binding and Receptor Oligomerization 101
Inter- and intracellular signaling in amyotrophic lateral sclerosis: role of p38 mitogen-activated protein kinase. 95
Heterogeneity of neuroinflammatory responses in amyotrophic lateral sclerosis: A challenge or an opportunity? 92
Hydrazone linked doxorubicin-PLA prodrug nanoparticles with high drug loading 90
Chemical, pharmacological and in vivo pharmacokinetic studies on enantiomerically pure RC-33 compounds, promising neuroprotective agents acting as sigma1 receptor agonists 87
Use of arylalkanolamines as sigma-1 receptor antagonists 84
Fast deep learning reconstruction techniques for preclinical magnetic resonance fingerprinting 82
Neuroprotective effects of the Sigma-1 receptor (S1R) agonist PRE-084,in a mouse model of motor neuron disease not linked to SOD1 mutation 81
Studies on the enantiomers of RC-33, promising neuroprotective agents acting as sigma1 receptor agonists. Isolation, configurational assignment and biological profile 80
Lack of changes in the PI3K/AKT survival pathway in the spinal cord motor neurons of a mouse model of familial amyotrophic lateral sclerosis. 77
Toward the identification of neuroprotective agents: G-scale synthesis, pharmacokinetic evaluation and CNS distribution of (R)-RC-33, a promising SIGMA1 receptor agonist 75
Delivery Platforms for CRISPR/Cas9 Genome Editing of Glial Cells in the Central Nervous System 75
Discovery of RC-752, a Novel Sigma-1 Receptor Antagonist with Antinociceptive Activity: A Promising Tool for Fighting Neuropathic Pain 74
Neurophysiological characterisation of the g93a ALS rat model 74
Unraveling the complexity of amyotrophic lateral sclerosis: recent advances from the transgenic mutant SOD1 mice. 73
Sigma1 Receptor Agonists in motor dysfunction pathologies treatment – a medicinal chemistry perspective 70
Haploinsufficiency at the CX3CR1 locus of hematopoietic stem cells favors the appearance of microglia-like cells in the central nervous system of transplant recipients 66
Biodegradable polymeric nanoparticles administered in the cerebrospinal fluid: Brain biodistribution, preferential internalization in microglia and implications for cell-selective drug release 63
Synthesis and characterization of a “clickable” pbr28 tspo-selective ligand derivative suitable for the functionalization of biodegradable polymer nanoparticles 63
Intracerebroventricular delivery of hematopoietic progenitors results in rapid and robust engraftment of microglia-like cells 62
Therapeutic efficacy of intracerebral hematopoietic stem cell gene therapy in an Alzheimer's disease mouse model 60
Novel S1R agonists counteracting NMDA excitotoxicity and oxidative stress: A step forward in the discovery of neuroprotective agents 57
Effect of Lipid Nanoparticle Physico-Chemical Properties and Composition on Their Interaction with the Immune System 56
Lentiviral vectors carrying enhancer elements of Hb9 promoter drive selective transgene expression in mouse spinal cord motor neurons. 55
Lipophilic dye-compatible brain clearing technique allowing correlative magnetic resonance/high-resolution fluorescence imaging in rat models of glioblastoma 55
Metallothioneins are neuroprotective agents in lysosomal storage disorders 51
An innovative hematopoietic stem cell gene therapy approach benefits CLN1 disease in the mouse model 50
T1-weighted dynamic contrast-enhanced MRI is a noninvasive marker of epidermal growth factor receptor VIII status in cancer stem cell-derived experimental glioblastomas 50
Simultaneous flow cytometric characterization of multiple cell types retrieved from mouse brain/spinal cord through different homogenization methods 44
null 9
Totale 3.696
Categoria #
all - tutte 14.780
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.780


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202140 0 0 0 0 0 0 0 0 0 18 16 6
2021/2022173 7 2 8 3 5 7 7 15 16 6 18 79
2022/2023529 56 54 1 33 43 58 0 29 231 2 12 10
2023/2024230 27 30 7 10 22 59 5 18 2 10 36 4
2024/2025651 20 44 13 18 23 72 35 34 159 26 68 139
2025/20261.478 112 78 283 171 182 70 272 65 147 98 0 0
Totale 3.696